{"gene":"MCCC2","run_date":"2026-06-10T02:59:50","timeline":{"discoveries":[{"year":2001,"finding":"MCCC2 (MCCB) encodes the non-biotin-containing beta-subunit of 3-methylcrotonyl-CoA carboxylase (MCC), a mitochondrial enzyme involved in leucine catabolism. Mutations in MCCB result in almost total loss of MCC enzyme activity in fibroblasts, establishing MCCC2 as necessary for MCC enzymatic function.","method":"cDNA cloning, gene characterization, patient mutation identification, enzyme activity assay in fibroblasts","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct enzyme activity measurement in patient-derived fibroblasts combined with mutation identification, replicated across multiple patients","pmids":["11406611"],"is_preprint":false},{"year":2003,"finding":"Missense mutations in MCCB (MCCC2) mapping to evolutionarily conserved residues cause null or severely diminished MCC enzymatic activity when expressed by transient transfection in SV40-transformed deficient fibroblasts, directly confirming their pathogenic mechanism.","method":"Transient transfection of mutant constructs into MCC-deficient fibroblasts followed by enzyme activity assay","journal":"Molecular genetics and metabolism","confidence":"High","confidence_rationale":"Tier 2 / Moderate — functional reconstitution in deficient cells with multiple mutations tested, single lab","pmids":["14680978"],"is_preprint":false},{"year":2021,"finding":"MCCC2 knockdown in HCC cells reduces leucine metabolism, decreases acetyl-CoA levels (a product of leucine metabolism), reduces glycolysis markers (glucose consumption, lactate secretion), and suppresses ERK activation. HCC cells with MCCC2 knocked out fail to respond to leucine deprivation, placing MCCC2 as a mediator of leucine-dependent metabolic signaling.","method":"siRNA/sgRNA knockdown, CCK-8, transwell assays, metabolite measurement (acetyl-CoA, glucose, lactate), ERK activation assay, mass spectrometry of binding proteins, in vivo xenograft","journal":"Cancer cell international","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal functional assays in a single lab with in vivo validation, but pathway placement inferred rather than mechanistically dissected","pmids":["33407468"],"is_preprint":false},{"year":2024,"finding":"ECHDC2 promotes ubiquitination and proteasomal degradation of MCCC2 protein by binding with the E3 ubiquitin ligase NEDD4, establishing NEDD4-mediated ubiquitination as a mechanism for MCCC2 protein turnover. This degradation suppresses the P38 MAPK pathway and aerobic glycolysis in gastric cancer cells.","method":"Co-immunoprecipitation, Western blotting, immunofluorescence, colony formation, CCK8, glycolysis assay, in vivo xenograft","journal":"Molecular medicine (Cambridge, Mass.)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP establishing ECHDC2-NEDD4-MCCC2 complex, multiple functional assays, single lab","pmids":["38783226"],"is_preprint":false},{"year":2023,"finding":"MCCC2 forms a protein complex with the telomere binding protein TRF2, as detected by co-immunoprecipitation. MCCC2 knockdown or knockout reduces telomere length without affecting telomerase (TERT) expression or activity, and alters mitochondrial morphology (increasing mitochondrial fusion markers MFN1, MFN2, OPA1), revealing a non-canonical role for MCCC2 linking mitochondria to telomere maintenance.","method":"Co-immunoprecipitation, siRNA knockdown, CRISPR knockout, telomere length measurement, TERT activity assay, Western blotting for fusion markers, transmission electron microscopy","journal":"Cellular & molecular biology letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with functional follow-up using multiple orthogonal methods, single lab","pmids":["37828426"],"is_preprint":false},{"year":2025,"finding":"SIRT4 directly deacetylates MCCC2 at lysine 269 (K269), which stabilizes the MCCC1/MCCC2 heterodimeric complex and enhances its enzymatic (carboxylase) activity, leading to increased acetyl-CoA production. This increased acetyl-CoA drives H3K27 acetylation and stem cell-like transcriptional reprogramming in HCC tumor-initiating cells.","method":"Deacetylation assay, site-directed mutagenesis (K269), co-immunoprecipitation of MCCC1/MCCC2 complex, MCC enzyme activity assay, acetyl-CoA measurement, H3K27 acetylation analysis, in vivo tumor growth assay","journal":"International journal of biological sciences","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct deacetylation with site-specific mutagenesis, complex formation validated by Co-IP, enzyme activity and downstream metabolite measured, in vivo validation, single lab","pmids":["40384857"],"is_preprint":false},{"year":2026,"finding":"MCCC2 directly interacts with LTBP1 (identified by LC-MS/MS and validated by co-immunoprecipitation and GST pulldown), and competitively inhibits SMURF1-mediated ubiquitination and degradation of LTBP1, thereby stabilizing LTBP1 and activating TGF-β signaling to drive prostate cancer bone metastasis.","method":"Liquid chromatography-mass spectrometry, co-immunoprecipitation, GST pulldown, ubiquitination assay, in vitro migration/invasion assays, in vivo bone metastasis model","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — direct protein interaction validated by orthogonal pulldown methods, ubiquitination mechanism defined, in vivo validation, single lab","pmids":["42251191"],"is_preprint":false},{"year":2026,"finding":"MCCC2 knockdown in TNBC cells inhibits mTOR signaling in a leucine-dependent manner: the inhibitory effects of MCCC2 knockdown were reversed by rapamycin and abolished under leucine-free culture conditions, placing MCCC2 upstream of leucine-dependent mTOR activation.","method":"siRNA knockdown, rapamycin treatment, leucine deprivation, proliferation/migration/invasion assays, bioinformatic pathway analysis","journal":"Breast cancer (Dove Medical Press)","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — genetic epistasis via pharmacological rescue with rapamycin plus leucine deprivation, but single lab with limited mechanistic detail in abstract","pmids":["41836158"],"is_preprint":false}],"current_model":"MCCC2 (MCCCβ/MCCB) encodes the non-biotin-containing beta-subunit of mitochondrial 3-methylcrotonyl-CoA carboxylase (MCC), which heterodimerizes with the biotin-containing MCCC1 alpha-subunit to catalyze leucine catabolism; SIRT4 deacetylates MCCC2 at K269 to stabilize the MCCC1/MCCC2 complex and enhance its carboxylase activity, thereby increasing acetyl-CoA production; MCCC2 protein stability is regulated by NEDD4-mediated ubiquitination and degradation (promoted by ECHDC2 binding); and beyond its metabolic role, MCCC2 interacts with TRF2 to influence telomere length and with LTBP1 to inhibit SMURF1-mediated ubiquitination and activate TGF-β signaling, while leucine metabolism through MCCC2 activates downstream mTOR and ERK signaling pathways in cancer cells."},"narrative":{"mechanistic_narrative":"MCCC2 encodes the non-biotin-containing beta-subunit of mitochondrial 3-methylcrotonyl-CoA carboxylase (MCC), heterodimerizing with the biotin-containing MCCC1 alpha-subunit to drive leucine catabolism, and patient mutations that map to conserved residues cause near-total loss of MCC enzymatic activity, establishing MCCC2 as essential for the holoenzyme's function [PMID:11406611, PMID:14680978]. The MCCC1/MCCC2 complex and its carboxylase activity are post-translationally tuned: SIRT4 directly deacetylates MCCC2 at K269, stabilizing the heterodimer and enhancing carboxylase activity to increase acetyl-CoA output [PMID:40384857], while MCCC2 protein abundance is limited by NEDD4-mediated ubiquitination and proteasomal degradation, an event promoted by ECHDC2 binding [PMID:38783226]. Through this leucine-to-acetyl-CoA metabolic axis, MCCC2 supports glycolysis and feeds nutrient-sensing signaling, acting upstream of leucine-dependent mTOR activation and of ERK and P38 MAPK signaling, and the SIRT4-driven acetyl-CoA increase fuels H3K27 acetylation and stem cell-like transcriptional reprogramming in tumor cells [PMID:33407468, PMID:38783226, PMID:40384857, PMID:41836158]. Beyond metabolism, MCCC2 has non-canonical roles: it complexes with the telomere-binding protein TRF2 and is required to maintain telomere length independently of telomerase, while also shaping mitochondrial fusion [PMID:37828426], and it directly binds LTBP1 to competitively block SMURF1-mediated ubiquitination of LTBP1, thereby stabilizing LTBP1 and activating TGF-β signaling [PMID:42251191].","teleology":[{"year":2001,"claim":"Established the molecular identity and essential function of MCCC2 by showing it encodes the non-biotin beta-subunit of MCC and that its loss abolishes leucine-catabolic carboxylase activity.","evidence":"cDNA cloning, patient mutation identification, and MCC enzyme activity assay in patient fibroblasts","pmids":["11406611"],"confidence":"High","gaps":["Did not resolve the structural basis of MCCC1/MCCC2 heterodimerization","No mechanism for how individual residues contribute to catalysis"]},{"year":2003,"claim":"Confirmed the pathogenic mechanism of specific MCCB missense alleles by demonstrating that conserved-residue mutations directly cripple MCC activity upon reconstitution.","evidence":"Transient transfection of mutant constructs into MCC-deficient fibroblasts followed by enzyme activity assay","pmids":["14680978"],"confidence":"High","gaps":["Did not map mutations onto a structural model","No distinction between effects on folding, stability, or catalytic chemistry"]},{"year":2021,"claim":"Placed MCCC2 within cancer metabolism by linking its leucine-catabolic activity to acetyl-CoA production, glycolysis, and ERK signaling in HCC cells.","evidence":"siRNA/sgRNA knockdown, metabolite measurement, ERK activation assay, and xenograft in HCC cells","pmids":["33407468"],"confidence":"Medium","gaps":["Pathway placement inferred rather than mechanistically dissected","No direct demonstration that acetyl-CoA mediates the ERK and glycolytic effects"]},{"year":2023,"claim":"Revealed a non-metabolic role by showing MCCC2 complexes with TRF2 and is required to maintain telomere length independently of telomerase, while influencing mitochondrial fusion.","evidence":"Co-immunoprecipitation, knockdown/knockout, telomere length and TERT activity assays, fusion-marker Western blot, and electron microscopy","pmids":["37828426"],"confidence":"Medium","gaps":["Mechanism connecting a mitochondrial enzyme to nuclear telomeres unresolved","Single Co-IP without structural characterization of the MCCC2-TRF2 interaction","Causal link between mitochondrial fusion changes and telomere effects not established"]},{"year":2024,"claim":"Defined how MCCC2 protein levels are controlled, identifying ECHDC2-promoted, NEDD4-mediated ubiquitination as the route to MCCC2 turnover with downstream effects on P38 MAPK and aerobic glycolysis.","evidence":"Reciprocal co-immunoprecipitation, Western blotting, glycolysis assays, and xenograft in gastric cancer cells","pmids":["38783226"],"confidence":"Medium","gaps":["Ubiquitination site(s) on MCCC2 not mapped","Direct E3-substrate transfer not reconstituted in vitro"]},{"year":2025,"claim":"Identified a post-translational activating mechanism: SIRT4 deacetylation of MCCC2 K269 stabilizes the MCCC1/MCCC2 complex, boosts carboxylase activity, and raises acetyl-CoA to drive H3K27 acetylation and stemness reprogramming.","evidence":"Deacetylation assay, K269 site-directed mutagenesis, complex Co-IP, enzyme activity and acetyl-CoA measurement, H3K27ac analysis, and in vivo tumor assay","pmids":["40384857"],"confidence":"High","gaps":["How K269 acetylation alters heterodimer affinity at the structural level unknown","Upstream signals controlling SIRT4 engagement of MCCC2 not defined"]},{"year":2026,"claim":"Established a moonlighting role in signaling, showing MCCC2 directly binds LTBP1 and competitively blocks SMURF1-mediated LTBP1 ubiquitination to activate TGF-β signaling and drive bone metastasis.","evidence":"LC-MS/MS, co-immunoprecipitation, GST pulldown, ubiquitination assay, and in vivo bone metastasis model in prostate cancer","pmids":["42251191"],"confidence":"High","gaps":["Whether this function requires catalytically active MCC is unclear","Subcellular site of the MCCC2-LTBP1 interaction not localized"]},{"year":2026,"claim":"Positioned MCCC2 upstream of leucine-dependent mTOR signaling, with rapamycin and leucine deprivation reversing the consequences of MCCC2 knockdown in TNBC cells.","evidence":"siRNA knockdown with rapamycin rescue and leucine-free culture, plus proliferation/migration/invasion assays","pmids":["41836158"],"confidence":"Medium","gaps":["Limited mechanistic detail linking MCCC2 metabolism to mTOR activation","Whether the effect is mediated by leucine flux versus a downstream metabolite untested"]},{"year":null,"claim":"It remains unresolved how MCCC2's canonical mitochondrial carboxylase activity is mechanistically coupled to its non-catalytic roles in telomere maintenance, TGF-β signaling, and nutrient-sensing pathways.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of MCCC2 in any of its complexes","No test of whether moonlighting functions depend on carboxylase activity or mitochondrial localization","Physiological versus cancer-specific relevance of the non-canonical roles not delineated"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016874","term_label":"ligase activity","supporting_discovery_ids":[0,1,5]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,5]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,4]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,2,5]}],"complexes":["3-methylcrotonyl-CoA carboxylase (MCC; MCCC1/MCCC2 heterodimer)"],"partners":["MCCC1","SIRT4","ECHDC2","NEDD4","TRF2","LTBP1","SMURF1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9HCC0","full_name":"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial","aliases":["3-methylcrotonyl-CoA carboxylase 2","3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit","3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta"],"length_aa":563,"mass_kda":61.3,"function":"Carboxyltransferase subunit of the 3-methylcrotonyl-CoA carboxylase, an enzyme that catalyzes the conversion of 3-methylcrotonyl-CoA to 3-methylglutaconyl-CoA, a critical step for leucine and isovaleric acid catabolism","subcellular_location":"Mitochondrion matrix","url":"https://www.uniprot.org/uniprotkb/Q9HCC0/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MCCC2","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/MCCC2","total_profiled":1310},"omim":[{"mim_id":"609014","title":"3-@METHYLCROTONYL-CoA CARBOXYLASE 2; MCCC2","url":"https://www.omim.org/entry/609014"},{"mim_id":"609010","title":"3-@METHYLCROTONYL-CoA CARBOXYLASE 1; MCCC1","url":"https://www.omim.org/entry/609010"},{"mim_id":"210210","title":"3-@METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D","url":"https://www.omim.org/entry/210210"},{"mim_id":"210200","title":"3-@METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D","url":"https://www.omim.org/entry/210200"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Mitochondria","reliability":"Enhanced"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"liver","ntpm":109.5}],"url":"https://www.proteinatlas.org/search/MCCC2"},"hgnc":{"alias_symbol":["MCCB","MCCCβ"],"prev_symbol":[]},"alphafold":{"accession":"Q9HCC0","domains":[{"cath_id":"3.90.226.10","chopping":"66-292","consensus_level":"high","plddt":97.6645,"start":66,"end":292},{"cath_id":"3.90.226.10","chopping":"313-471_518-548","consensus_level":"high","plddt":97.8889,"start":313,"end":548}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9HCC0","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9HCC0-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9HCC0-F1-predicted_aligned_error_v6.png","plddt_mean":94.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MCCC2","jax_strain_url":"https://www.jax.org/strain/search?query=MCCC2"},"sequence":{"accession":"Q9HCC0","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9HCC0.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9HCC0/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9HCC0"}},"corpus_meta":[{"pmid":"16835865","id":"PMC_16835865","title":"Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA and MCCB mutations and impact on risk assessment.","date":"2006","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/16835865","citation_count":67,"is_preprint":false},{"pmid":"19494832","id":"PMC_19494832","title":"How the MccB bacterial ancestor of ubiquitin E1 initiates biosynthesis of the microcin C7 antibiotic.","date":"2009","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/19494832","citation_count":63,"is_preprint":false},{"pmid":"11406611","id":"PMC_11406611","title":"Cloning of the human MCCA and MCCB genes and mutations therein reveal the molecular cause of 3-methylcrotonyl-CoA: carboxylase deficiency.","date":"2001","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11406611","citation_count":33,"is_preprint":false},{"pmid":"30026096","id":"PMC_30026096","title":"Biosynthesis and characterization of polyhydroxyalkanoate from marine Bacillus cereus MCCB 281 utilizing glycerol as carbon source.","date":"2018","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/30026096","citation_count":30,"is_preprint":false},{"pmid":"22264772","id":"PMC_22264772","title":"A single mutation in MCCC1 or MCCC2 as a potential cause of positive screening for 3-methylcrotonyl-CoA carboxylase deficiency.","date":"2011","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/22264772","citation_count":27,"is_preprint":false},{"pmid":"27868364","id":"PMC_27868364","title":"Production and characterization of polyhydroxybutyrate from Vibrio harveyi MCCB 284 utilizing glycerol as carbon source.","date":"2016","source":"Journal of applied microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/27868364","citation_count":27,"is_preprint":false},{"pmid":"33407468","id":"PMC_33407468","title":"MCCC2 promotes HCC development by supporting leucine oncogenic function.","date":"2021","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/33407468","citation_count":26,"is_preprint":false},{"pmid":"38783226","id":"PMC_38783226","title":"ECHDC2 inhibits the proliferation of gastric cancer cells by binding with NEDD4 to degrade MCCC2 and reduce aerobic glycolysis.","date":"2024","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/38783226","citation_count":21,"is_preprint":false},{"pmid":"14680978","id":"PMC_14680978","title":"Functional analysis of MCCA and MCCB mutations causing methylcrotonylglycinuria.","date":"2003","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/14680978","citation_count":16,"is_preprint":false},{"pmid":"37828426","id":"PMC_37828426","title":"MCCC2 is a novel mediator between mitochondria and telomere and functions as an oncogene in colorectal cancer.","date":"2023","source":"Cellular & molecular biology letters","url":"https://pubmed.ncbi.nlm.nih.gov/37828426","citation_count":15,"is_preprint":false},{"pmid":"32302772","id":"PMC_32302772","title":"Marine actinomycetes Nocardiopsis alba MCCB 110 has immunomodulatory property in the tiger shrimp Penaeus monodon.","date":"2020","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32302772","citation_count":15,"is_preprint":false},{"pmid":"33548322","id":"PMC_33548322","title":"Biocompatibility of polyhydroxybutyrate-co-hydroxyvalerate films generated from Bacillus cereus MCCB 281 for medical applications.","date":"2021","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/33548322","citation_count":12,"is_preprint":false},{"pmid":"28401470","id":"PMC_28401470","title":"Streptomyces artemisiae MCCB 248 isolated from Arctic fjord sediments has unique PKS and NRPS biosynthetic genes and produces potential new anticancer natural products.","date":"2017","source":"3 Biotech","url":"https://pubmed.ncbi.nlm.nih.gov/28401470","citation_count":11,"is_preprint":false},{"pmid":"21071250","id":"PMC_21071250","title":"Novel mutations in the human MCCA and MCCB gene causing methylcrotonylglycinuria.","date":"2010","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/21071250","citation_count":10,"is_preprint":false},{"pmid":"17465309","id":"PMC_17465309","title":"Synechocystis MCCB 114 and 115 as putative probionts for Penaeus monodon post-larvae.","date":"2007","source":"Diseases of aquatic organisms","url":"https://pubmed.ncbi.nlm.nih.gov/17465309","citation_count":10,"is_preprint":false},{"pmid":"34015495","id":"PMC_34015495","title":"A novel substituted derivative of sterol from marine actinomycetes Nocardiopsis alba MCCB 110 antagonistic to the aquaculture pathogen Vibrio harveyi.","date":"2021","source":"Microbial pathogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/34015495","citation_count":8,"is_preprint":false},{"pmid":"24617020","id":"PMC_24617020","title":"Potential application of beta-1, 3 glucanase from an environmental isolate of Pseudomonas aeruginosa MCCB 123 in fungal DNA extraction.","date":"2014","source":"Indian journal of experimental biology","url":"https://pubmed.ncbi.nlm.nih.gov/24617020","citation_count":8,"is_preprint":false},{"pmid":"40384857","id":"PMC_40384857","title":"SIRT4 Controls Acetyl-CoA Synthesis to Promote Stemness and Invasiveness of Hepatocellular Carcinoma through Deacetylating MCCC2.","date":"2025","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40384857","citation_count":1,"is_preprint":false},{"pmid":"33423264","id":"PMC_33423264","title":"[Analysis of MCCC2 gene variant in a pedigree affected with 3-methylcrotonyl coenzyme A carboxylase deficiency].","date":"2021","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33423264","citation_count":1,"is_preprint":false},{"pmid":"40459729","id":"PMC_40459729","title":"Prospects of Synthetic Biology-Based Approaches in the Enhanced Production of Pyocyanin in Pseudomonas aeruginosa MCCB 117 as the Drug of Choice in Aquaculture.","date":"2025","source":"Current microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/40459729","citation_count":1,"is_preprint":false},{"pmid":"41836158","id":"PMC_41836158","title":"Inhibition of MCCC2 Impedes TNBC Progression by Downregulating Leucine Metabolism-Dependent mTOR Signaling.","date":"2026","source":"Breast cancer (Dove Medical Press)","url":"https://pubmed.ncbi.nlm.nih.gov/41836158","citation_count":0,"is_preprint":false},{"pmid":"40044138","id":"PMC_40044138","title":"Functional importance of Ser323 in cysteine desulfhydrase and cystathionine gamma-lyase MccB of Staphylococcus aureus.","date":"2025","source":"Journal of microbiology (Seoul, Korea)","url":"https://pubmed.ncbi.nlm.nih.gov/40044138","citation_count":0,"is_preprint":false},{"pmid":"42251191","id":"PMC_42251191","title":"MCCC2 stabilizes LTBP1 via suppressing SMURF1-dependent ubiquitination to drive bone metastasis in prostate cancer.","date":"2026","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/42251191","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.03.31.25324806","title":"Efficacy and Safety of Transcranial Temporal Interference Stimulation for Improving Negative Symptoms and Cognition in Schizophrenia: A Pilot Study","date":"2025-04-01","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.31.25324806","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.02.24.25322813","title":"Randomized Double Blind Inpatient Study of a Gluten-Free Diet in Persons with Schizophrenia","date":"2025-02-25","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.24.25322813","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":14842,"output_tokens":2256,"usd":0.039183,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9379,"output_tokens":3345,"usd":0.06526,"stage2_stop_reason":"end_turn"},"total_usd":0.104443,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"MCCC2 (MCCB) encodes the non-biotin-containing beta-subunit of 3-methylcrotonyl-CoA carboxylase (MCC), a mitochondrial enzyme involved in leucine catabolism. Mutations in MCCB result in almost total loss of MCC enzyme activity in fibroblasts, establishing MCCC2 as necessary for MCC enzymatic function.\",\n      \"method\": \"cDNA cloning, gene characterization, patient mutation identification, enzyme activity assay in fibroblasts\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct enzyme activity measurement in patient-derived fibroblasts combined with mutation identification, replicated across multiple patients\",\n      \"pmids\": [\"11406611\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Missense mutations in MCCB (MCCC2) mapping to evolutionarily conserved residues cause null or severely diminished MCC enzymatic activity when expressed by transient transfection in SV40-transformed deficient fibroblasts, directly confirming their pathogenic mechanism.\",\n      \"method\": \"Transient transfection of mutant constructs into MCC-deficient fibroblasts followed by enzyme activity assay\",\n      \"journal\": \"Molecular genetics and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional reconstitution in deficient cells with multiple mutations tested, single lab\",\n      \"pmids\": [\"14680978\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"MCCC2 knockdown in HCC cells reduces leucine metabolism, decreases acetyl-CoA levels (a product of leucine metabolism), reduces glycolysis markers (glucose consumption, lactate secretion), and suppresses ERK activation. HCC cells with MCCC2 knocked out fail to respond to leucine deprivation, placing MCCC2 as a mediator of leucine-dependent metabolic signaling.\",\n      \"method\": \"siRNA/sgRNA knockdown, CCK-8, transwell assays, metabolite measurement (acetyl-CoA, glucose, lactate), ERK activation assay, mass spectrometry of binding proteins, in vivo xenograft\",\n      \"journal\": \"Cancer cell international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal functional assays in a single lab with in vivo validation, but pathway placement inferred rather than mechanistically dissected\",\n      \"pmids\": [\"33407468\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ECHDC2 promotes ubiquitination and proteasomal degradation of MCCC2 protein by binding with the E3 ubiquitin ligase NEDD4, establishing NEDD4-mediated ubiquitination as a mechanism for MCCC2 protein turnover. This degradation suppresses the P38 MAPK pathway and aerobic glycolysis in gastric cancer cells.\",\n      \"method\": \"Co-immunoprecipitation, Western blotting, immunofluorescence, colony formation, CCK8, glycolysis assay, in vivo xenograft\",\n      \"journal\": \"Molecular medicine (Cambridge, Mass.)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP establishing ECHDC2-NEDD4-MCCC2 complex, multiple functional assays, single lab\",\n      \"pmids\": [\"38783226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"MCCC2 forms a protein complex with the telomere binding protein TRF2, as detected by co-immunoprecipitation. MCCC2 knockdown or knockout reduces telomere length without affecting telomerase (TERT) expression or activity, and alters mitochondrial morphology (increasing mitochondrial fusion markers MFN1, MFN2, OPA1), revealing a non-canonical role for MCCC2 linking mitochondria to telomere maintenance.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, CRISPR knockout, telomere length measurement, TERT activity assay, Western blotting for fusion markers, transmission electron microscopy\",\n      \"journal\": \"Cellular & molecular biology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with functional follow-up using multiple orthogonal methods, single lab\",\n      \"pmids\": [\"37828426\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"SIRT4 directly deacetylates MCCC2 at lysine 269 (K269), which stabilizes the MCCC1/MCCC2 heterodimeric complex and enhances its enzymatic (carboxylase) activity, leading to increased acetyl-CoA production. This increased acetyl-CoA drives H3K27 acetylation and stem cell-like transcriptional reprogramming in HCC tumor-initiating cells.\",\n      \"method\": \"Deacetylation assay, site-directed mutagenesis (K269), co-immunoprecipitation of MCCC1/MCCC2 complex, MCC enzyme activity assay, acetyl-CoA measurement, H3K27 acetylation analysis, in vivo tumor growth assay\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct deacetylation with site-specific mutagenesis, complex formation validated by Co-IP, enzyme activity and downstream metabolite measured, in vivo validation, single lab\",\n      \"pmids\": [\"40384857\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"MCCC2 directly interacts with LTBP1 (identified by LC-MS/MS and validated by co-immunoprecipitation and GST pulldown), and competitively inhibits SMURF1-mediated ubiquitination and degradation of LTBP1, thereby stabilizing LTBP1 and activating TGF-β signaling to drive prostate cancer bone metastasis.\",\n      \"method\": \"Liquid chromatography-mass spectrometry, co-immunoprecipitation, GST pulldown, ubiquitination assay, in vitro migration/invasion assays, in vivo bone metastasis model\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — direct protein interaction validated by orthogonal pulldown methods, ubiquitination mechanism defined, in vivo validation, single lab\",\n      \"pmids\": [\"42251191\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"MCCC2 knockdown in TNBC cells inhibits mTOR signaling in a leucine-dependent manner: the inhibitory effects of MCCC2 knockdown were reversed by rapamycin and abolished under leucine-free culture conditions, placing MCCC2 upstream of leucine-dependent mTOR activation.\",\n      \"method\": \"siRNA knockdown, rapamycin treatment, leucine deprivation, proliferation/migration/invasion assays, bioinformatic pathway analysis\",\n      \"journal\": \"Breast cancer (Dove Medical Press)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — genetic epistasis via pharmacological rescue with rapamycin plus leucine deprivation, but single lab with limited mechanistic detail in abstract\",\n      \"pmids\": [\"41836158\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MCCC2 (MCCCβ/MCCB) encodes the non-biotin-containing beta-subunit of mitochondrial 3-methylcrotonyl-CoA carboxylase (MCC), which heterodimerizes with the biotin-containing MCCC1 alpha-subunit to catalyze leucine catabolism; SIRT4 deacetylates MCCC2 at K269 to stabilize the MCCC1/MCCC2 complex and enhance its carboxylase activity, thereby increasing acetyl-CoA production; MCCC2 protein stability is regulated by NEDD4-mediated ubiquitination and degradation (promoted by ECHDC2 binding); and beyond its metabolic role, MCCC2 interacts with TRF2 to influence telomere length and with LTBP1 to inhibit SMURF1-mediated ubiquitination and activate TGF-β signaling, while leucine metabolism through MCCC2 activates downstream mTOR and ERK signaling pathways in cancer cells.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"MCCC2 encodes the non-biotin-containing beta-subunit of mitochondrial 3-methylcrotonyl-CoA carboxylase (MCC), heterodimerizing with the biotin-containing MCCC1 alpha-subunit to drive leucine catabolism, and patient mutations that map to conserved residues cause near-total loss of MCC enzymatic activity, establishing MCCC2 as essential for the holoenzyme's function [#0, #1]. The MCCC1/MCCC2 complex and its carboxylase activity are post-translationally tuned: SIRT4 directly deacetylates MCCC2 at K269, stabilizing the heterodimer and enhancing carboxylase activity to increase acetyl-CoA output [#5], while MCCC2 protein abundance is limited by NEDD4-mediated ubiquitination and proteasomal degradation, an event promoted by ECHDC2 binding [#3]. Through this leucine-to-acetyl-CoA metabolic axis, MCCC2 supports glycolysis and feeds nutrient-sensing signaling, acting upstream of leucine-dependent mTOR activation and of ERK and P38 MAPK signaling, and the SIRT4-driven acetyl-CoA increase fuels H3K27 acetylation and stem cell-like transcriptional reprogramming in tumor cells [#2, #3, #5, #7]. Beyond metabolism, MCCC2 has non-canonical roles: it complexes with the telomere-binding protein TRF2 and is required to maintain telomere length independently of telomerase, while also shaping mitochondrial fusion [#4], and it directly binds LTBP1 to competitively block SMURF1-mediated ubiquitination of LTBP1, thereby stabilizing LTBP1 and activating TGF-\\u03b2 signaling [#6].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Established the molecular identity and essential function of MCCC2 by showing it encodes the non-biotin beta-subunit of MCC and that its loss abolishes leucine-catabolic carboxylase activity.\",\n      \"evidence\": \"cDNA cloning, patient mutation identification, and MCC enzyme activity assay in patient fibroblasts\",\n      \"pmids\": [\n        \"11406611\"\n      ],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Did not resolve the structural basis of MCCC1/MCCC2 heterodimerization\",\n        \"No mechanism for how individual residues contribute to catalysis\"\n      ]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Confirmed the pathogenic mechanism of specific MCCB missense alleles by demonstrating that conserved-residue mutations directly cripple MCC activity upon reconstitution.\",\n      \"evidence\": \"Transient transfection of mutant constructs into MCC-deficient fibroblasts followed by enzyme activity assay\",\n      \"pmids\": [\n        \"14680978\"\n      ],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Did not map mutations onto a structural model\",\n        \"No distinction between effects on folding, stability, or catalytic chemistry\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Placed MCCC2 within cancer metabolism by linking its leucine-catabolic activity to acetyl-CoA production, glycolysis, and ERK signaling in HCC cells.\",\n      \"evidence\": \"siRNA/sgRNA knockdown, metabolite measurement, ERK activation assay, and xenograft in HCC cells\",\n      \"pmids\": [\n        \"33407468\"\n      ],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Pathway placement inferred rather than mechanistically dissected\",\n        \"No direct demonstration that acetyl-CoA mediates the ERK and glycolytic effects\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Revealed a non-metabolic role by showing MCCC2 complexes with TRF2 and is required to maintain telomere length independently of telomerase, while influencing mitochondrial fusion.\",\n      \"evidence\": \"Co-immunoprecipitation, knockdown/knockout, telomere length and TERT activity assays, fusion-marker Western blot, and electron microscopy\",\n      \"pmids\": [\n        \"37828426\"\n      ],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism connecting a mitochondrial enzyme to nuclear telomeres unresolved\",\n        \"Single Co-IP without structural characterization of the MCCC2-TRF2 interaction\",\n        \"Causal link between mitochondrial fusion changes and telomere effects not established\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined how MCCC2 protein levels are controlled, identifying ECHDC2-promoted, NEDD4-mediated ubiquitination as the route to MCCC2 turnover with downstream effects on P38 MAPK and aerobic glycolysis.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation, Western blotting, glycolysis assays, and xenograft in gastric cancer cells\",\n      \"pmids\": [\n        \"38783226\"\n      ],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Ubiquitination site(s) on MCCC2 not mapped\",\n        \"Direct E3-substrate transfer not reconstituted in vitro\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Identified a post-translational activating mechanism: SIRT4 deacetylation of MCCC2 K269 stabilizes the MCCC1/MCCC2 complex, boosts carboxylase activity, and raises acetyl-CoA to drive H3K27 acetylation and stemness reprogramming.\",\n      \"evidence\": \"Deacetylation assay, K269 site-directed mutagenesis, complex Co-IP, enzyme activity and acetyl-CoA measurement, H3K27ac analysis, and in vivo tumor assay\",\n      \"pmids\": [\n        \"40384857\"\n      ],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How K269 acetylation alters heterodimer affinity at the structural level unknown\",\n        \"Upstream signals controlling SIRT4 engagement of MCCC2 not defined\"\n      ]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Established a moonlighting role in signaling, showing MCCC2 directly binds LTBP1 and competitively blocks SMURF1-mediated LTBP1 ubiquitination to activate TGF-\\u03b2 signaling and drive bone metastasis.\",\n      \"evidence\": \"LC-MS/MS, co-immunoprecipitation, GST pulldown, ubiquitination assay, and in vivo bone metastasis model in prostate cancer\",\n      \"pmids\": [\n        \"42251191\"\n      ],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether this function requires catalytically active MCC is unclear\",\n        \"Subcellular site of the MCCC2-LTBP1 interaction not localized\"\n      ]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Positioned MCCC2 upstream of leucine-dependent mTOR signaling, with rapamycin and leucine deprivation reversing the consequences of MCCC2 knockdown in TNBC cells.\",\n      \"evidence\": \"siRNA knockdown with rapamycin rescue and leucine-free culture, plus proliferation/migration/invasion assays\",\n      \"pmids\": [\n        \"41836158\"\n      ],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Limited mechanistic detail linking MCCC2 metabolism to mTOR activation\",\n        \"Whether the effect is mediated by leucine flux versus a downstream metabolite untested\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how MCCC2's canonical mitochondrial carboxylase activity is mechanistically coupled to its non-catalytic roles in telomere maintenance, TGF-\\u03b2 signaling, and nutrient-sensing pathways.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No structural model of MCCC2 in any of its complexes\",\n        \"No test of whether moonlighting functions depend on carboxylase activity or mitochondrial localization\",\n        \"Physiological versus cancer-specific relevance of the non-canonical roles not delineated\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\n        \"term_id\": \"GO:0016874\",\n        \"supporting_discovery_ids\": [\n          0,\n          1,\n          5\n        ]\n      },\n      {\n        \"term_id\": \"GO:0016740\",\n        \"supporting_discovery_ids\": [\n          0,\n          5\n        ]\n      }\n    ],\n    \"localization\": [\n      {\n        \"term_id\": \"GO:0005739\",\n        \"supporting_discovery_ids\": [\n          0,\n          4\n        ]\n      }\n    ],\n    \"pathway\": [\n      {\n        \"term_id\": \"R-HSA-1430728\",\n        \"supporting_discovery_ids\": [\n          0,\n          2,\n          5\n        ]\n      }\n    ],\n    \"complexes\": [\n      \"3-methylcrotonyl-CoA carboxylase (MCC; MCCC1/MCCC2 heterodimer)\"\n    ],\n    \"partners\": [\n      \"MCCC1\",\n      \"SIRT4\",\n      \"ECHDC2\",\n      \"NEDD4\",\n      \"TRF2\",\n      \"LTBP1\",\n      \"SMURF1\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":3,"faith_total":4,"faith_pct":75.0}}